Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open Clinical Investigation to Confirm the Effectiveness and Safety of Hemoclin Gel for the Treatment of Haemorrhoids.

NCT05124379 is registered in ClinicalTrials.gov with Karo Pharma AB as lead sponsor.

NCT NCT05124379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05124379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open Clinical Investigation to Confirm the Effectiveness and Safety of Hemoclin Gel for the Treatment of Haemorrhoids.
Lead sponsor
Karo Pharma AB
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2021
Completion date
January 19, 2022
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoids grade i and ii